Specifically, proteins exhibiting alterations in two distinct cohorts of RA patients with both early and established disease, including CTSL-1, SORT1, SAA4, TNFRSF10A, ST6GAL1 and CCL-18. Here, CCL18 is linked to rheumatoid arthritis.